Selective decontamination of the digestive tract in burn patients: An evidence-based maneuver that reduces mortality

Journal of Burn Care and Research

Volumn 31, Issue 2, 2010, Pages 372-373

  Silvestri, Luciano ^a   De La Cal, Miguel A ^b   Taylor, Nia ^c   Van Saene, Hendrick K F ^c   Parodi, Pier Camillo ^d  

^a Presidio Ospedaliero ^*  (Italy)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; POLYMYXIN; TOBRAMYCIN; VANCOMYCIN;

ASEPSIS; BLOODSTREAM INFECTION; BURN PATIENT; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE UNIT; LETTER; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; RISK REDUCTION; SELECTIVE DIGESTIVE DECONTAMINATION; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BURNS; DECONTAMINATION; DRUG RESISTANCE, MICROBIAL; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL TRACT; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 77649322603     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181d1b61f     Document Type: Letter

References (17)

1. Mosier MJ, Pham TN. American Burn Association practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2009;30:910-918
2. van Saene HK, Silvestri L, de la Cal MA, Baines P. The emperor's new clothes: the fairy tale continues. J Crit Care 2009; 24:149-152
3. Silvestri L, van Saene HKF, Weir I, Gullo A. Survival benefit of the full selective digestive decontamination regimen. J Crit Care 2009;24:474.e7-14
4. Abdel-Razek SM, Abdel-Khalek AH, Allam AM, Shalaby H, Mandoor S, Higazi M. Impact of selective gastrointestinal decontamination on mortality and morbidity in severely burned patients. Ann Burns Fire Disasters 2000;13:213-215
5. Barret JP, Jeschke MG, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001;27:439-445
6. de la Cal MA, Cerdá E, García-Hierro P, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebocontrolled, double-blind trial. Ann Surg 2005;241:424-430
7. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of the digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised trial. Lancet 2003;362:1011-1016
8. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
9. Silvestri L, van Saene HKF. Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Crit Care Med 2006;34:2027-2030
10. van Saene HK, Taylor N, Damjanovic V, Sarginson RE. Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr Drug Targets 2008;9:419-421
11. Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients.AmJ Infect Control 2002;30:391-399
12. de la Cal MA, Cerdá E, van Saene HK, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/ surgical intensive care unit. J Hosp Infect 2004;56: 175-183
13. Viviani M, van Saene HK, Dezzoni R, et al. Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a doseresponse study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 2005;33:361-372
14. Silvestri L, van Saene HKF, Milanese M, et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 2004;23:921-926
15. Cerdá E, Abella A, de la Cal MA, et al. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study. Ann Surg 2007;245:397-407.
16. Kimura A, Mochizuki T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T. Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients. J Trauma 1998;45: 383-387
17. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003:CD003340.